VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

Virus Evol. 2024 Mar 6;10(1):veae018. doi: 10.1093/ve/veae018. eCollection 2024.

Abstract

Viral mutations within patients nurture the adaptive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein, we describe Viral Intra-Patient Evolution Reporting and Analysis (VIPERA), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, which revealed population dynamics and evidence of adaptive evolution. VIPERA is available under a free software license at https://github.com/PathoGenOmics-Lab/VIPERA.

Keywords: SARS-CoV-2; bioinformatics; intra-patient diversity; serially sampled infection; snakemake workflow; within-host evolution.